Breakout
Date & Time:
February 15, 2026
3:45 PM – 5:15 PM PT
Format:
In Person & Virtual
CE Credits:
1.5 Hours
UAN: JA0002345-0000-26-022-L01-P
Course level:
Intermediate
Pediatric Content Included
session objectives:
What You'll Learn
- Assess the current data on obesity medications with a focus on efficacy and safety.
- Apply nutritional principles that optimize treatment outcomes for patients on GLP-1s.
- Evaluate ethical considerations for obesity management.
- Determine the landscape of insurance coverage and access challenges for GLP-1s.
Topics & Presenters
Obesity Medications and Evidence for Use in Children and Adolescents
Celtina Reinert
PharmD, CSP
Clinical Pharmacist Specialist
Weight Management, Allergy, Severe Asthma, Rheumatology, Dermatology, Children's Mercy Kansas City
Kansas City,
MO
Nutrition Highlights for Patients on Obesity Medication
Lora Edwards
MSEd, RD, CSSD, CSOWM, LD
Clinical Nutrition Specialist
Nutrition Department, Children's Mercy Kansas City
Kansas City,
MO
Ethical Considerations of Obesity Treatment
Cristina Fernandez
MD
Professor
School of Medicine, University of Missouri Kansas City
Physician
Center for Children's Health Lifestyles and Nutrition, Children's Mercy Kansas City
Kansas City,
MO
Obesity Medication Coverage and Access Challenges
Kristin Streiler
MD
Assistant Professor of Pediatrics
University of Kansas Health System
Kansas City,
KS
Moderators:
Celtina Reinert
PharmD, CSPClinical Pharmacist Specialist
Weight Management, Allergy, Severe Asthma, Rheumatology, Dermatology, Children's Mercy Kansas City
Kansas City,
MO